Study Enrollment

Your details will not be published or shared.

Clinical Trial

FITE19: Evaluation of the Efficacy and Safety of PTC299 in Hospitalized Subjects with COVID-19 (PTC299-VIR-015-COV19)

The purpose of this study is to see how effective the study drug PTC299 is compared with placebo bnased on the time to respiratory improvement in adult subjects hospitalized with COVID19.

Eligibility Criteria

  • INCLUSION: 1. Adult age 18 or older, hospitalized with lab-confirmed COVID, and imaging-confirmed lung involvement 2. Vital signs, oxygenation within protocol-defined parameters EXCLUSION: 1. On ventilator 2. Lab values or medical conditions not allowed by study 3. Planned transfer to a non-study site hospital within 72 hours.

Contact Information

    Aprile Osborn`

    (706) 721-0309